Adaptimmune Therapeutics Plc PEG
What is the PEG of Adaptimmune Therapeutics Plc?
The PEG of Adaptimmune Therapeutics Plc is N/A
What is the definition of PEG?
Price/earnings to growth (PEG) ratio is a stock’s P/E ratio divided by a predicted growth rate of its earnings for a time period of 5 years.
= forward PE / 5-year EPS growth rate
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG of companies in the Health Care sector on NASDAQ compared to Adaptimmune Therapeutics Plc
What does Adaptimmune Therapeutics Plc do?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Companies with peg similar to Adaptimmune Therapeutics Plc
- Ecopetrol SA has PEG of N/A
- Medley Capital Corp has PEG of N/A
- AGNC Investment Corp has PEG of N/A
- Liberty Media has PEG of N/A
- Acacia Communications Inc has PEG of N/A
- Smart Sand Inc has PEG of N/A
- Adaptimmune Therapeutics Plc has PEG of N/A
- TeraGo has PEG of N/A
- Kennametal has PEG of N/A
- Telstra has PEG of N/A
- Oracle Services Software has PEG of N/A
- Hecla Mining Co has PEG of N/A
- Kirkland`s Inc has PEG of N/A